FRANKFURT--The following is a summary of analysts' forecasts for AstraZeneca plc (AZN) second-quarter results, based on a poll of 10 analysts conducted by Dow Jones Newswires (figures in million dollars, EPS and dividend in dollar, target price in pence, according to IFRS). Earnings figures are scheduled to be released July 30.

=== 
                 Sales:        -Seroquel 
2nd Quarter      -Total -Nexium       XR -Symbicort -Crestor 
AVERAGE           5,706     559      265      848      1,263 
Prev. Year        6,454     971      304      928      1,450 
+/- in %            -12     -42      -13      -8.6       -13 
 
MEDIAN            5,672     557      265      841      1,243 
Maximum           6,124     589      270      908      1,325 
Minimum           5,481     513      258      815      1,216 
Amount               10       7        6        7          7 
 
Bernstein         5,481     513      265      835      1,233 
Cowen and Company 5,715     580      270      815      1,325 
Credit Suisse     5,715      --       --       --         -- 
Deutsche Bank     5,629     556      258      861      1,269 
Exane BNP Paribas 5,559     574      269      823      1,243 
J.P. Morgan       6,124      --       --       --         -- 
Pareto Securities 5,552     589      260      841      1,242 
Kepler Cheuvreux  5,617     544      265      856      1,216 
Morgan Stanley    5,883     557       --      908      1,313 
Pareto Securities 5,781      --       --       --         -- 
 
                   Core:              -Net 
                -Operat.           attrib. 
2nd Quarter       profit    -PBT    profit    -EPS 
AVERAGE            1,733   1,607     1,321    1.04 
Prev. Year         2,031   1,890     1,642    1.30 
+/- in %             -15     -15       -20     -20 
 
MEDIAN             1,756   1,610     1,332    1.06 
Maximum            1,787   1,653     1,368    1.08 
Minimum            1,626   1,540     1,250    0.91 
Amount                10       5         7      10 
 
Bernstein          1,715   1,584     1,297    1.03 
Cowen and Company  1,725   1,610     1,320    1.05 
Credit Suisse      1,750      --        --    1.07 
Deutsche Bank      1,776   1,653     1,342    1.06 
Exane BNP Paribas  1,762      --     1,339    1.06 
J.P. Morgan        1,764      --        --    1.07 
Jefferies          1,772   1,647     1,332    1.05 
Kepler Cheuvreux   1,787      --     1,368    1.08 
Morgan Stanley     1,650   1,540     1,250    0.99 
Pareto Securities  1,626      --        --    0.91 
 
 
            Target price  Rating                 DPS 2015 
AVERAGE            5.090  positive 3     AVERAGE     2.80 
Prev. Quarter      5.039  neutral  2     Prev. Year  2.80 
+/- in %            +1.0  negative 2     +/- in %      -- 
 
MEDIAN             5.200                 MEDIAN      2.80 
Maximum            5.500                 Maximum     2.80 
Minimum            4.500                 Minimum     2.79 
Amount                 5                 Amount         5 
 
Berenberg          5.200  Buy                          -- 
Deutsche Bank      4.850  Hold                       2.80 
Exane BNP Paribas  5.500  Outperform                 2.80 
J.P. Morgan           --  Neutral                      -- 
Jefferies          5.400  Buy                        2.80 
Morgan Stanley     4.500  Underweight                2.79 
Pareto Securities     --  Sell                       2.80 
=== 

Year-earlier figures are as reported by the company.

DJG/voi 

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more AstraZeneca Charts.
AstraZeneca (NYSE:AZN)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more AstraZeneca Charts.